Abstract
Ethinylœstradiol was administered to 10 post-menopausal hyperparathyroid patients. There was a gradual fall in the fasting plasma-calcium and urine-calcium and in the 24-hour- urine calcium and hydroxyproline, which was maintained up to one year in the patients who continued therapy. Œstrogen treatment of hyperparathyroidism in post-menopausal women might be expected to prevent bone disease by inhibiting bone resorption, and stone disease by reducing urine-calcium.
Original language | English (US) |
---|---|
Pages (from-to) | 503-507 |
Number of pages | 5 |
Journal | The Lancet |
Volume | 299 |
Issue number | 7749 |
DOIs | |
State | Published - Mar 4 1972 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Medicine(all)